
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Review Article: Individualised Management of Reflux-Like Symptoms—Strategies Beyond Acid Suppression</title>
<style>

<style>
body {
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
    background: linear-gradient(135deg, #f0f4ff, #fafafa);
    color: #2c2c2c;
    padding: 40px;
}

/* Mindmap container */
.mindmap {
    max-width: 900px;
    margin: auto;
    font-size: 16px;
    line-height: 1.7;
}

.mindmap ul {
    margin: 0.5em 0 1em 1em;
    padding-left: 1.5em;
    list-style: disc;
    color: #555;
    font-size: 0.95em;
    font-weight: 400;
    line-height: 1.6;
}

.mindmap li::marker {
    color: #a855f7; /* prettier bullets */
}

.mindmap li {
    margin-bottom: 6px;
    padding-left: 4px;
}


/* Collapsible sections */
.mindmap details {
    border-left: 4px solid #8b5cf6;
    background: #ffffff;
    margin: 15px 0;
    padding: 16px 20px;
    border-radius: 16px;
    box-shadow: 0 4px 12px rgba(139, 92, 246, 0.12);
    transition: all 0.3s ease;
    position: relative;
}

/* Hover glow */
.mindmap details:hover {
    box-shadow: 0 6px 18px rgba(139, 92, 246, 0.2);
    background: linear-gradient(135deg, #ffffff, #f3f0ff);
}

/* Summary styling */
.mindmap summary {
    cursor: pointer;
    font-size: 1.15em;
    font-weight: 600;
    list-style: none;
    position: relative;
    padding-left: 28px;
    color: #4c1d95;
}

/* Custom arrow */
.mindmap summary::before {
    content: "▶";
    position: absolute;
    left: 0;
    top: 2px;
    transition: transform 0.3s ease;
    font-size: 1em;
    color: #7c3aed;
}

.mindmap details[open] > summary::before {
    transform: rotate(90deg);
}

/* Titles */
.mindmap summary strong {
    display: block;
    font-size: 1.3em;
    color: #4c1d95;
}

.mindmap summary em {
    font-style: normal;
    color: #6b21a8;
    font-size: 0.95em;
}

/* Description bullets */
.mindmap ul {
    padding-left: 22px;
    margin-top: 10px;
    margin-bottom: 12px;
}

.mindmap li {
    margin-bottom: 6px;
    font-size: 0.97em;
    color: #444;
    list-style-type: disc;
    position: relative;
    padding-left: 4px;
}

/* Nesting indent style */
.mindmap details > div > details {
    margin-left: 20px;
    border-color: #a855f7;
    background: #f9f5ff;
}

/* Fade-in effect */
.mindmap details[open] > div {
    animation: fadeIn 0.3s ease-in;
}

/* Description box */
.mindmap .desc-box {
    background: #fdfcff;
    border: 1px solid #e5d9fb;
    border-left: 4px solid #c084fc;
    padding: 4px 6px;
    margin: 12px 0 18px 0;
    border-radius: 12px;
    box-shadow: 0 1px 3px rgba(160, 104, 255, 0.06);
    transition: background 0.3s ease;
}

.mindmap .desc-box:hover {
    background: #f9f4ff;
}


button {
    background-color: #7c3aed;
    color: white;
    border: none;
    padding: 10px 16px;
    margin: 0 6px;
    font-size: 1em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease;
}
button:hover {
    background-color: #6b21a8;
}


@keyframes fadeIn {
    from { opacity: 0; transform: translateY(-3px); }
    to { opacity: 1; transform: translateY(0); }
}


#level-controls button {
    background-color: rgba(124, 58, 237, 0.7); /* semi-transparent purple */
    color: white;
    border: none;
    padding: 8px 14px;
    margin: 0 6px;
    font-size: 1em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease, transform 0.2s;
}

#level-controls button:hover {
    background-color: rgba(107, 33, 168, 0.85); /* slightly darker on hover */
    transform: scale(1.05);
}

#level-controls {
    position: fixed;
    bottom: 20px;
    left: 50%;
    transform: translateX(-50%);
    background: rgba(124, 58, 237, 0.1);
    padding: 8px 14px;
    border-radius: 12px;
    box-shadow: 0 4px 10px rgba(0, 0, 0, 0.1);
    z-index: 9999;
    backdrop-filter: blur(6px);
    cursor: move; /* shows move cursor */
}

</style>




</style>
</head>
<body>
<div id="level-controls" onmousedown="dragElement(this)">
    <button onclick="setMindmapLevel(1)">Level 1</button>
    <button onclick="setMindmapLevel(2)">Level 2</button>
    <button onclick="setMindmapLevel(3)">Level 3</button>
</div>

<div class="mindmap">

    <div class="mindmap">
        
        <details>
            <summary><strong>Review Article: Individualised Management of Reflux-Like Symptoms—Strategies Beyond Acid Suppression</strong></summary>
            <div>
                <ul><li>Authors: Peter J. Kahrilas, Laurie Keefer, Rena Yadlapati, et al.</li><li>Journal: Alimentary Pharmacology &amp; Therapeutics</li><li>Publication Date: 2025</li><li>DOI: https://doi.org/10.1111/apt.70115</li><li>Focus: Pathophysiology &amp; management of reflux-like symptoms, emphasizing strategies beyond acid suppression.</li></ul>
                
        <details>
            <summary><strong>Knowledge Test</strong></summary>
            <div>
                <ul><li>1. What percentage of gastroscopies for upper GI symptoms are conducted for reflux or dyspepsia?</li><li>2. What is the adjusted positive predictive value for identifying cancer in patients undergoing gastroscopy for reflux-like symptoms?</li><li>3. What is the primary focus of brain-gut behavior therapies (BGBT) in managing reflux-like symptoms?</li><li>4. What score range does the Oesophageal Hypervigilance and Anxiety Scale (EHAS) provide?</li><li>5. What dietary practice from Japanese culture promotes heightened awareness of satiety cues?</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Introduction</strong></summary>
            <div>
                <ul><li>Reflux-like symptoms are frequently treated with PPIs, often long-term &amp; at high doses.</li><li>These symptoms are often conflated w/ reflux oesophagitis, assuming similar responsiveness to acid suppression.</li><li>However, many patients report persistent symptoms despite optimized PPI therapy, questioning this approach.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Methods</strong></summary>
            <div>
                <ul><li>A panel of 10 experts (primary care, gastroenterology, psychology) held online meetings.</li><li>They shared perspectives on pathophysiology &amp; management of reflux-like symptoms when PPIs are ineffective/partially effective.</li><li>The goal was to enhance care via personalized strategies from a primary care/generalist perspective.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Pathophysiology</strong></summary>
            <div>
                <ul><li>Focuses on understanding the underlying mechanisms of reflux oesophagitis &amp; reflux-like symptoms.</li><li>Highlights the role of acid reflux, psychological factors, &amp; visceral hypersensitivity.</li><li>Emphasizes the importance of differentiating between reflux oesophagitis &amp; NERD.</li></ul>
                
        <details>
            <summary><strong>Reflux Oesophagitis</strong></summary>
            <div>
                <ul><li>Characterized by endoscopically visible mucosal breaks in the distal oesophagus.</li><li>Graded by the Los Angeles Classification (A-D) based on severity.</li><li>Pathophysiology centers on anti-reflux barrier incompetence → ↑ gastro-oesophageal acid reflux &amp; poor oesophageal clearance.</li></ul>
                
        <details>
            <summary><strong>Key Factors</strong></summary>
            <div>
                <ul><li>Hypotensive lower oesophageal sphincter.</li><li>Dilatation of the diaphragmatic hiatus.</li><li>Hiatal hernia.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Treatment &amp; Management</strong></summary>
            <div>
                <ul><li>Healed w/ potent antisecretory therapy (PPIs or PCABs).</li><li>Physiological defects often require open-ended maintenance therapy.</li><li>Alternative strategies: intensive weight loss or surgery.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>&#x27;Typical&#x27; Reflux-Like Symptoms</strong></summary>
            <div>
                <ul><li>Defined by heartburn, chest pain, &amp; regurgitation (Montreal Consensus).</li><li>Most individuals w/ typical symptoms do not have reflux oesophagitis → NERD.</li><li>Further classified by pH-metry/pH-impedance testing: true NERD, reflux hypersensitivity, functional heartburn.</li></ul>
                
        <details>
            <summary><strong>Classifications</strong></summary>
            <div>
                <ul><li>True NERD: Abnormal oesophageal acid exposure.</li><li>Reflux hypersensitivity: Normal acid exposure, significant symptom-reflux correlation.</li><li>Functional heartburn: Normal acid exposure, no symptom-reflux correlation.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Poor Correlation</strong></summary>
            <div>
                <ul><li>Poor correlation between symptoms &amp; reflux events.</li><li>Disconnect between symptom severity &amp; physiological abnormality.</li><li>Psychological stressors, cognitive-affective factors, &amp; coping behaviors modulate symptom experience.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Oesophageal Hypervigilance and Anxiety Scale (EHAS)</strong></summary>
            <div>
                <ul><li>Quantifies oesophagus-focused anxiety &amp; symptom vigilance.</li><li>15-item questionnaire, scores 0-60.</li><li>EHAS score correlates w/ symptom severity, regardless of NERD subtype.</li></ul>
                
        <details>
            <summary><strong>EHAS-7</strong></summary>
            <div>
                <ul><li>Shorter 7-item version.</li><li>Performs as well as original.</li><li>Easier to implement in clinical practice.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Psychosocial Factors</strong></summary>
            <div>
                <ul><li>Study of 393 &#x27;PPI-refractory&#x27; patients: psychological variables predict symptom severity better than reflux-related variables.</li><li>Machine-learning model: psychological factors accounted for 88% of variance in symptom severity scores.</li><li>Reflux-related variables had lower predictive worth.</li></ul>
                
        <details>
            <summary><strong>Key Psychological Variables</strong></summary>
            <div>
                <ul><li>Depressive symptoms (worth = 0.210).</li><li>Illness behavior (worth = 0.165).</li><li>PTSD symptoms (worth = 0.128).</li><li>GI-specific anxiety (worth = 0.117).</li><li>Pain catastrophizing (worth = 0.114).</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Disorders of Gut-Brain Interaction (DGBIs)</strong></summary>
            <div>
                <ul><li>Psychological comorbidities &amp; visceral hypersensitivity play a dominant role in symptom perception.</li><li>DGBIs (functional heartburn, dyspepsia, IBS) commonly overlap.</li><li>Adaptation responses influence symptom experience; rationalization improves coping.</li></ul>
                
        <details>
            <summary><strong>Oesophageal Hypervigilance</strong></summary>
            <div>
                <ul><li>Behavioral reaction: increased attention to oesophageal symptoms &amp; settings.</li><li>Leads to &#x27;expecting&#x27; symptoms &amp; maladaptive coping behaviors.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>&#x27;Atypical&#x27; Reflux Symptoms</strong></summary>
            <div>
                <ul><li>Include laryngitis, pharyngitis, post-nasal drip, otitis, asthma.</li><li>Establishing reflux as a cause is problematic; affected patients rarely have reflux oesophagitis.</li><li>pH-metry/pH-impedance metry are used, but interpretation lacks consensus.</li></ul>
                
        <details>
            <summary><strong>Key Principles</strong></summary>
            <div>
                <ul><li>Reflux is rarely the dominant cause of extra-oesophageal syndromes w/o typical oesophageal symptoms.</li><li>Even when involved, reflux is usually one of multiple contributors.</li><li>Diagnostics are more helpful in ruling out GERD than ruling it in.</li><li>Strong tendency to over-treat w/ PPIs.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Laryngeal Symptoms</strong></summary>
            <div>
                <ul><li>Elevated hypervigilance &amp; anxiety (EHAS) in patients w/ &amp; w/o abnormal oesophageal pH-metry.</li><li>Highlights need for approaches beyond acid reduction.</li><li>Heterogeneity exists: some phenotypes driven by abnormal reflux, others by hypersensitivity &amp; behavioral factors.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Overlapping Gastrointestinal Symptoms</strong></summary>
            <div>
                <ul><li>Dyspeptic symptoms frequently overlap w/ reflux-like symptoms in PPI &#x27;non-responders&#x27;.</li><li>Functional heartburn has more in common w/ functional dyspepsia than reflux disease.</li><li>IBS overlaps more frequently w/ functional heartburn than true NERD/reflux hypersensitivity.</li></ul>
                
        <details>
            <summary><strong>Clinical Implications</strong></summary>
            <div>
                <ul><li>Differentiate between dyspeptic &amp; reflux-like symptoms.</li><li>Avoid medical jargon; use easy-to-understand tools (pictograms).</li><li>H. pylori testing is important in dyspepsia, not indicated in typical reflux-like symptoms.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Potential Lifestyle Contributors to Reflux-Like Symptoms</strong></summary>
            <div>
                <ul><li>Identifies dietary habits, weight gain, &amp; obesity as factors that can exacerbate reflux-like symptoms.</li><li>Highlights the importance of lifestyle modifications in managing these symptoms.</li><li>Focuses on practical strategies to address these contributors.</li></ul>
                
        <details>
            <summary><strong>Dietary Habits</strong></summary>
            <div>
                <ul><li>Poor habits (eating past satiety, close to bedtime) are associated w/ gastro-oesophageal reflux.</li><li>Large meals cause gastric distention, ↑ acid secretion, &amp; trigger transient lower oesophageal sphincter relaxations.</li><li>Dietary triggers vary widely; common ones include coffee, alcohol, chocolate, fatty/fried foods, processed foods.</li></ul>
                
        <details>
            <summary><strong>Carbonated Beverages</strong></summary>
            <div>
                <ul><li>Shown to increase the risk of heartburn during sleep.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Weight Gain, Obesity and Hiatal Hernia</strong></summary>
            <div>
                <ul><li>Reflux-like symptoms increase w/ BMI, even among normal weight individuals.</li><li>Obesity is a risk factor for reflux complications (oesophagitis, Barrett&#x27;s, adenocarcinoma).</li><li>Hiatal hernia &amp; ↑ intra-abdominal pressure are important physiological risk factors linked to obesity.</li></ul>
                
        <details>
            <summary><strong>Hiatal Hernia</strong></summary>
            <div>
                <ul><li>Spectrum of disruption of the diaphragmatic hiatus is age-related.</li><li>Excessive abdominal straining can also cause hiatal hernia in normal weight individuals.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Individualised Management Strategies</strong></summary>
            <div>
                <ul><li>Emphasizes patient-centered care w/ personalized strategies.</li><li>Focuses on addressing physiological, behavioral, &amp; dietary factors.</li><li>Highlights the importance of expectation setting &amp; counseling.</li></ul>
                
        <details>
            <summary><strong>Expectation Setting and Counselling</strong></summary>
            <div>
                <ul><li>Reflux-like symptoms have a multifactorial pathophysiology &amp; wax/wane.</li><li>PPI continuation is individualized based on benefit &amp; preference.</li><li>&#x27;PPI failure&#x27; may be due to unrealistic expectations rather than PPI efficacy.</li></ul>
                
        <details>
            <summary><strong>Key Components</strong></summary>
            <div>
                <ul><li>Understand patient&#x27;s circumstances, perceptions, symptom type, severity, comorbidities, &amp; alarm features.</li><li>Counsel on multifactorial aetiology, including the gut-brain connection.</li><li>Explain the gut-brain axis in patient-friendly language; reassure patients symptoms are not &#x27;all in the mind&#x27;.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Doctor-Patient Relationship</strong></summary>
            <div>
                <ul><li>Key to holistic management based on patient experience.</li><li>Use active listening, show compassion, &amp; build rapport.</li><li>Use PRO tools (EHAS, GERDQ, GIS, QOLRAD) to make consultations interactive &amp; effective.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Reassurance</strong></summary>
            <div>
                <ul><li>Reassure patients that the risk of oesophageal cancer is extremely low.</li><li>Gastroscopy has low diagnostic yield for symptom evaluation (0.2% positive predictive value for reflux-like symptoms).</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Diet and Lifestyle Changes</strong></summary>
            <div>
                <ul><li>Key element of care for all patients w/ reflux-like symptoms.</li><li>Dietary &amp; lifestyle contributors are highly individualized.</li><li>Expert consensus: avoid high-fat foods, dietary triggers, overeating, &amp; recumbency after meals.</li></ul>
                
        <details>
            <summary><strong>Practical Strategies</strong></summary>
            <div>
                <ul><li>Use smaller plates.</li><li>Set a cut-off time for the last meal (3-h interval before bedtime).</li><li>Raise the head of the bed.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Mindful Eating</strong></summary>
            <div>
                <ul><li>Promote awareness of satiety cues by paying attention to flavors, textures, &amp; chewing.</li><li>Pre-meal mantra: &#x27;hara hachi bu&#x27; (eat until 80% full).</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Weight Management</strong></summary>
            <div>
                <ul><li>Recommended for overweight/obese patients &amp; those who have recently gained weight.</li><li>Weight loss reduces symptoms dose-dependently &amp; increases treatment success.</li><li>PPI + tailored diet/exercise program → greater symptom improvement &amp; PPI discontinuation in &gt;50% of patients.</li></ul>
                
        <details>
            <summary><strong>Interventions</strong></summary>
            <div>
                <ul><li>Specific intervention depends on local services.</li><li>GLP-1RA may support weight loss as an adjunct to diet &amp; exercise.</li><li>Some short-acting GLP-1RAs may ↑ risk of oesophagitis &amp; Barrett&#x27;s in type 2 diabetes.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Atypical (Laryngopharyngeal) Symptoms</strong></summary>
            <div>
                <ul><li>PPI treatment has little benefit over placebo.</li><li>Disconnect between objective findings &amp; symptom severity.</li><li>Paradigm shift: phenotype-driven, personalized approach acknowledging psychosocial factors.</li></ul>
                
        <details>
            <summary><strong>Key Factors</strong></summary>
            <div>
                <ul><li>Chronicity is laryngeal hypersensitivity amplified by anxiety, hypervigilance, &amp; detrimental behaviors.</li><li>Laryngeal Cognitive-Affective Tool (LCAT) measures laryngeal hypervigilance &amp; symptom-specific anxiety.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Psychological Interventions</strong></summary>
            <div>
                <ul><li>Brain-gut behavior therapies (BGBT) may be beneficial for patients w/ stress-related symptoms, coping difficulties, &amp; avoidance behaviors.</li><li>BGBTs reduce symptom severity &amp; psychological symptoms, improving QoL.</li><li>EHAS tool gauges symptom-associated anxiety &amp; hypervigilance.</li></ul>
                
        <details>
            <summary><strong>Good Candidates</strong></summary>
            <div>
                <ul><li>Accept &amp; show interest in the gut-brain connection.</li><li>Acknowledge coping could be improved.</li><li>Willing to invest time in behavior change.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>BGBT Techniques</strong></summary>
            <div>
                <ul><li>Nurse-led GI self-management skills training.</li><li>GI-focused CBT.</li><li>Gut-directed hypnotherapy.</li><li>Mindfulness-based interventions.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Hypnotherapy Example</strong></summary>
            <div>
                <ul><li>Oesophageal-directed hypnotherapy improved heartburn impact (QOLRAD, p=0.01), visceral anxiety (p=0.01), &amp; emotional QoL (p=0.05).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Implementation</strong></summary>
            <div>
                <ul><li>Combination of techniques can individualize therapy.</li><li>Primary care can implement nurse-led self-management skills training.</li><li>Stress management &amp; relaxation techniques are key components.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Atypical Symptoms</strong></summary>
            <div>
                <ul><li>BGBT may be relevant for patients w/ chronic atypical symptoms &amp; laryngeal-specific anxiety/hypervigilance.</li><li>Laryngeal recalibration therapy (cognitive behavioral element) had 85% symptomatic response.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Diaphragmatic Breathing</strong></summary>
            <div>
                <ul><li>May be effective for reducing reflux-like symptoms.</li><li>Activates parasympathetic nervous system, increases lower oesophageal sphincter pressure &amp; crural diaphragm tension.</li><li>Useful for patients w/ regurgitation; helps relaxation by increasing vagal tone.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>On-Demand Symptom Control Measures</strong></summary>
            <div>
                <ul><li>Alternative to continuous PPI therapy.</li><li>Antacid/alginate-antacid products are useful for postprandial acid reflux &amp; regurgitation, especially w/ hiatal hernia.</li><li>Alginate-antacid forms a viscous pH-neutral raft, reducing acid reflux &amp; displacing the acid pocket.</li></ul>
                
        <details>
            <summary><strong>Efficacy</strong></summary>
            <div>
                <ul><li>Meta-analyses show efficacy for symptom control vs. placebo &amp; non-inferiority to some PPIs.</li><li>Bioadhesive treatments (hyaluronic acid-chondroitin sulphate) may reduce symptoms by protecting the mucosa.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Adjunct Therapy</strong></summary>
            <div>
                <ul><li>On-demand therapy can be useful as an alternative to dose escalation.</li><li>Alginate or bioadhesive agents added to PPIs can reduce residual symptoms.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Summary</strong></summary>
            <div>
                <ul><li>PPIs are effective for healing reflux oesophagitis, but less so for persistent/atypical reflux symptoms.</li><li>This is due to differences in pathophysiology: anatomical/physiological degradation vs. cognitive-affective/behavioral processes.</li><li>Hypersensitivity, hypervigilance, &amp; anxiety correlate w/ symptom severity &amp; persistence.</li></ul>
                
        <details>
            <summary><strong>Management Approach</strong></summary>
            <div>
                <ul><li>Individualized for patients, starting w/ expectation setting &amp; counseling.</li><li>Utilize behavior modification (diet/lifestyle, weight control), education on brain-gut interactions, psychological interventions, &amp; on-demand symptom control.</li><li>Acid suppression is just one of several interventions in an individualized approach.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
    </div>
    
</div>


<script>
function setMindmapLevel(level) {
    const allDetails = document.querySelectorAll('.mindmap details');

    // Close all
    allDetails.forEach(detail => detail.removeAttribute('open'));

    // Open based on depth
    allDetails.forEach(detail => {
        let depth = 0;
        let parent = detail.parentElement;
        while (parent && parent.tagName !== 'BODY') {
            if (parent.tagName === 'DETAILS') depth++;
            parent = parent.parentElement;
        }
        if (depth < level) detail.setAttribute('open', '');
    });
}

// Automatically open to level 1 on page load
window.addEventListener('DOMContentLoaded', () => {
    setMindmapLevel(1);
});

function dragElement(elmnt) {
    let pos1 = 0, pos2 = 0, pos3 = 0, pos4 = 0;

    const onMouseDown = (e) => {
        e.preventDefault();
        pos3 = e.clientX;
        pos4 = e.clientY;
        document.onmouseup = closeDragElement;
        document.onmousemove = elementDrag;
    };

    const elementDrag = (e) => {
        e.preventDefault();
        pos1 = pos3 - e.clientX;
        pos2 = pos4 - e.clientY;
        pos3 = e.clientX;
        pos4 = e.clientY;
        elmnt.style.top = (elmnt.offsetTop - pos2) + "px";
        elmnt.style.left = (elmnt.offsetLeft - pos1) + "px";
        elmnt.style.transform = "none"; // cancel centering transform
        elmnt.style.bottom = "auto"; // cancel fixed bottom
    };

    const closeDragElement = () => {
        document.onmouseup = null;
        document.onmousemove = null;
    };

    onMouseDown(event);
}
</script>


</body>
</html>
